Colleen Maiden is a recognized leader in cell and gene therapy operations, with more than a decade of experience advancing access to high-quality cell source materials and clinical apheresis programs. She has worked extensively with hospitals, research organizations, and biopharma partners to streamline processes, reduce risk, and accelerate therapy development. Passionate about bridging clinical and operational needs, Colleen brings a practical, patient-focused perspective to the challenges and opportunities shaping the future of cell therapy.